Evidence map›Paper›PMID 40303495›Full record

ReviewInternational journal of medical sciences2025

Heterogeneity of Renal Endothelial Cells, Interact with Neighboring Cells, and Endothelial Injury in Chronic Kidney Disease: Mechanisms and Therapeutic Implications.

Meiyu Zhang, Wu Liu, Haoran Dai, Hanxue Jiang, Qihan Zhao, Wenbin Liu, Hongliang Rui, Baoli Liu

Abstract readReview
In one paragraph

Review in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meiyu ZhangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Wu LiuBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Haoran DaiShunyi Branch, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100310, China.
Hanxue JiangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Qihan ZhaoBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Wenbin LiuBeijing University of Chinese Medicine, Beijing 100029, China.
Hongliang RuiBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Baoli LiuBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is closely associated with endothelial dysfunction, leading to symptoms such as albuminuria, edema, and coagulopathy. Recent advancements in single-cell sequencing have deepened our understanding of the heterogeneity of renal endothelial cells, which is significantly influenced by their microenvironment. Understanding the influence of neighboring cells on endothelial heterogeneity is essential for elucidating the mechanisms underlying vascular dysfunction and CKD progression. This review explores the latest research on renal endothelial cell heterogeneity and their interactions with neighboring cells. We further discuss the mechanisms of endothelial injury in CKD, including alterations to the endothelial glycocalyx, inflammation, oxidative stress, and dysfunction of the glomerular filtration barrier. Renal endothelial injury contributes to complications, including cardiovascular disease, diabetic nephropathy, and impaired vascular function. Therapeutic strategies encompass antihypertensive, hypoglycemic, and lipid-lowering treatments, supplemented by emerging approaches such as anti-inflammatory therapies, gene therapy, and lifestyle modifications. Through reviewing the relationship between endothelial injury and CKD progression, we emphasize potential strategies to enhance prognosis and mitigate disease progression.

Indexed as

Endothelial CellsEndothelium, VascularKidneyRenal Insufficiency, ChronicAnimalsDisease ProgressionGlomerular Filtration BarrierHumansOxidative StressChronic Kidney DiseaseEndothelial dysfunctionEndothelial HeterogeneityEndothelial injury

Identifiers

PMID40303495
PMCPMC12035827

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.